A registered dietitian can create a personalized eating plan to help you manage side effects, ensure youre getting proper nutrients, and develop healthy habits that will last a lifetime
Oral semaglutide (Rybelsus) Oral semaglutide is the only FDA-approved oral GLP-1 medication
For a detailed head-to-head analysis including dosing charts , efficacy data, and practical recommendations, see our dedicated comparison guides
However, research suggests that up to 40% of the weight lost while on GLP-1s may come from lean body mass, which includes muscle and bone

Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended
